CorMedix Inc (CRMD) — Free Cash Flow Yield
Biotech & Pharma
| Metric | Value |
|---|---|
| FCF Yield | 33.0% |
| Biotech & Pharma Sector Avg FCF Yield | 16.3% |
| Annual Free Cash Flow | $195M |
| Market Cap | $591M |
| P/E Ratio | 3.2x |
CorMedix Inc's FCF yield of 33.0% is above the Biotech & Pharma sector average (16.3%).
Frequently Asked Questions
What is CorMedix Inc's (CRMD) free cash flow yield?
CorMedix Inc's (CRMD) free cash flow yield is 33.0%. That is above the Biotech & Pharma sector average (16.3%).
Is CRMD's free cash flow yield good?
At 33.0%, CRMD's free cash flow yield is considered excellent — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does CorMedix Inc generate?
CorMedix Inc generated $195M in free cash flow, against a market cap of $591M.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →